CybrHawk

CybrHawk

Whats Happening With PFE Stock?

Investors have punished PFE stock lately, amid declining revenue and margins. An activist investor – Starboard – built a $1 billion position in PFE stock a few months back, and it has stated that Pfizer has overspent on its recent acquisitions. Furthermore, Pfizer has withdrawn the sickle cell disease candidate it currency trading indicators acquired in a $5.4 billion deal with Global Blood Therapeutics, raising concerns over management’s decisions on R&D spending. President Donald Trump said tariffs on pharmaceuticals will be coming in the “not too distant future” and fit in the category of tariffs imposed on cars, steel, and aluminum.

Pfizer ends development of weight-loss pill danuglipron

The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. In 2024, the FDA’s Center for Drug Evaluation and Research (CDER) approved 50 new drugs. The CDER director, Patrizia Cavazzoni, M.D., stepped down in January and joined Pfizer’s C-suite as chief medical officer.

Pfizer hits setback in obesity drug race as GLP-1 trial halts

Albert Bourla, who has been with Pfizer for more than 25 years, is currently the company’s chief executive officer (CEO) and chairman. Before assuming the CEO position in January 2019, he was chief operating officer (COO) starting in January 2018. From February 2016 to December 2018, Bourla was group president of Pfizer’s Global Vaccines, Oncology, and Consumer Healthcare business. He was president and general manager of the company’s Established Products business from 2010 to 2013. Bourla served in a number of other roles from 1993, when he joined the company, to 2010.

Investor Services

2021 highlights include 8 FDA approvals, four new regulatory submissions and 13 new trial startups. Pfizer is also a well-known dividend payer and has returned more than $8.7 billion to shareholders since going public. Albert Bourla is the pharmaceutical giant’s current chief executive officer (CEO). Pfizer is classified as a member of the S&P 500 healthcare sector and operates within the biotechnology and pharmaceutical industry.

Inc. (MRK), Switzerland-based Roche Holding AG (RHHBY), and Eli Lilly and Co. (LLY). Pfizer reported adjusted net income attributable to its common shareholders of $25.2 billion on $81.3 billion in annual revenue in its 2021 fiscal year (FY). The company traces its origins to the founding of Charles Pfizer & Co. in Brooklyn, N.Y., in 1849 by Charles Pfizer and Charles Erhart. The company expanded during the late 1800s and early 1900s, remaining a privately held company until June 1942, when it offered shares of its common stock to the public for the first time.

Premium Investing Services

  • And when considering the strength of its earnings outlook, PFE sticks out at as one of the market’s strongest value stocks.
  • On May 10, 2021, the FDA expanded the EUA for the Pfizer-BioNTech vaccine to include adolescents ages 12–15.
  • The biopharma has a robust pipeline with potential mega blockbuster cancer drugs a…

Pfizer is also working on a once-a-day version of its weight-loss pill – danuglipron – and scrapped a twice-daily version of the drug late last year, amid high rate of side effects. The company’s top seller in 2021 was Comirnaty, a COVID-19 vaccine. It generated nearly $37 billion in 2021 and was followed by Prevnar, Ibrance and Eliquis with just over $5 billion in sales each. Other blockbuster names on Pfizer’s list include Xeljanz and Enbrel, each bringing in $3.5 billion. Pfizer operates 39 research and production facilities worldwide and sells its canadian forex review products in 125 countries.

Nvidia (NVDA) says it will make it the first artificial intelligence (AI) supercomputer in the US, marking heavy investment in the US while President Trump imposes hefty tariffs on foreign imports. Intel (INTC) sells its controlling stake in Altera to Silver Lake. To watch how to read stock charts for beginners more expert insights and analysis on the latest market action, check out more Morning Brief here. Tariffs can impact the corporate bottom lines in several ways, both directly and indirectly. Notably, the increased import costs put more pressure on the margins. While some firms can decide to alleviate the pressure by increasing the prices for customers, others can choose to absorb them, says the firm.

The two were German immigrants and chemists that set up shops outside New York City to make medicinal compounds. The first major success was an antiparasitic called santonin, and the commercialization of citric acid-making technologies quickly followed that up. Their success with citric acid led to the company’s expansion and other major discoveries. Discover which analysts rank highest on predicting the price target of PFE. On Oct. 29, 2021, the FDA extended the EUA for the vaccine to include children ages 5–11.

Morningstar, while quoting FactSet’s consensus estimates, mentioned that analysts expect 6.8% earnings growth in Q1 for companies in the S&P 500 benchmark index. Goldman Sachs highlighted that equities around the world traded in and out of a bear market — which is often defined as a 20% decline from the recent peak. According to Peter Oppenheimer, chief global equity strategist at Goldman Sachs Research, the history of bear markets can provide some clues regarding the duration and severity of such downturns. U.S. stocks ended significantly higher after Trump announced his decision to put a 90-day pause on the additional country-specific portion of the reciprocal tariffs.

  • The Trump administration’s proposed tariffs on pharmaceuticals have caused significant market turmoil today, with major Pharma stocks plummeting globally.
  • On April 14, the company told investors it would scrap development of danuglipron, its oral GLP-1 candidate for weight management.
  • The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security.

There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for a deeply undervalued AI stock that is more promising than PFE but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock. Pfizer (PFE 0.43%) recently reminded investors how risky the drug-development business can be. On April 14, the company told investors it would scrap development of danuglipron, its oral GLP-1 candidate for weight management.

Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month.

(0.18%), Rhumbline Advisers (0.17%), Fifth Third Bancorp (0.05%) and Wealth Enhancement Advisory Services LLC (0.05%). Insiders that own company stock include Pfizer Inc, William R Carapezzi Jr, Ronald E Blaylock, Jennifer B Damico and Scott Gottlieb. Pfizer Inc. was founded in 1849 by Charles Pfizer Sr. and his cousin Charles Earhart.

Falling sales clubbed with lower margin has weighed on Pfizer’s bottom line over the recent years. Trump doubled down on plans to soon impose “major” pharmaceutical tariffs, while early stage startups dominated digital health funding deals in first quarter. Sign-up to receive the latest news and ratings for Pfizer and its competitors with MarketBeat’s FREE daily newsletter. World War I caused a shortage of materials for making citric acid and forced the company to seek alternatives. The one they latched on to was the fermentation of certain fungi known to produce citric acid naturally. This led to the advancement of fermentation technology that was later used in the commercial production of penicillin and then the advancement of antibiotics in general.

Leave a Reply

Your email address will not be published. Required fields are marked *